Creative Biogene Creative Biogene
Inquiry
Pages
Products
  1. Home
  2. AI
AI-Driven Gene Editing and Therapy
AI-Antibody Engineering Fusion
AI-Driven Enzyme Engineering
AI-Enhanced Small Molecule Screening
AI-Driven Protein Degrader Drug Development

AI-Powered Biopharmaceutical R&D

In today's era of deep integration between artificial intelligence and biotechnology, Creative Biogene introduces a comprehensive AI service matrix covering the full spectrum of research and development needs, including antibody engineering, gene editing, enzyme optimization, and bioprocess development. Based on our proprietary algorithms and industry-leading wet lab validation systems, we are committed to providing global research institutions and pharmaceutical companies with precise, efficient, and translatable AI solutions.

Contact Us

AI-Driven Gene Editing and Therapy

1. Intelligent mRNA Sequence

Optimization Deep Learning Pipeline

Integrates ORF codon usage optimization (CAI>0.95), UTR dynamic structure prediction (RNA-Bart model), and GC content balancing (35%-65%), achieving a 5-8-fold increase in protein expression.

Experimental Validation Module

Ensures optimization consistency through CHO cell transient transfection and ELISA quantification.

2. Gene Editing Vector Design

sgRNA off-target prediction

Employs Convolutional Neural Networks (CNN) to analyze genome-wide potential cutting sites, achieving specificity scores >90%.

Lentiviral vector optimization

Enhances transduction efficiency to >95% through promoter activity prediction models and integration site preference analysis.

Multi-species gene editing

Supports multi-species gene knockout/knock-in (including primary cells and iPSCs) with a 6-week delivery timeline.

3. Stable Cell Line Development

Trains LSTM models on metabolomics data to dynamically regulate media components (e.g., glucose/glutamine ratio), achieving a 3-fold increase in CHO cell antibody expression.

Provides monoclonality verification (via microfluidic sorting) and genetic stability testing (>15 continuous passages).

AI-Antibody Engineering Fusion

Epitope-Guided Antibody Design

Integrates deep characterization of natural antibody libraries with bidirectional LSTM-CRF hybrid models for de novo design and optimization of CDR regions, generating millions of candidate molecules and screening for high-potential antibodies with binding energies below -9.0 kcal/mol.

Combines AlphaFold2 and RosettaFold to predict antibody-antigen complex 3D structures, precisely identifying epitope binding hotspots and optimizing binding interface charge complementarity.

Dynamic Affinity Maturation

Employs Graph Neural Networks (GNN) to construct 5-mer, 7-mer, and 9-mer virtual libraries, combined with Molecular Dynamics (MD) simulations for conformational stability assessment, achieving 4x higher hit rates than traditional phage display.

Supports multi-parameter optimization: solubility, immunogenicity, and thermal stability.

Antibody Function Validation Loop Wet Lab Integration

Validates AI predictions through Surface Plasmon Resonance (SPR) and cell-killing assays, ensuring consistency between binding affinity (KD<1nM) and functional activity (EC50<10nM). Provides downstream engineering services including IgG subtype conversion and Fc fucosylation modification to enhance ADCC/ADCP effects.

AI-Driven Enzyme Engineering

Supports activity-stability-solubility triple screening of million-scale mutant libraries, improving positive rates from 0.1% to 12%.

Predicts enzyme stability in extreme temperatures (>70°C) or organic solvents with RMSD error<0.15 Å.

ASRA Algorithm enhances stereoselectivity to >99% through an adaptive base substitution strategy.

Combines microfluidic chip validation, reducing iteration cycles.

AI-Enhanced Small Molecule Screening

01

Intelligent Target Profiling

  • Al identifies binding pockets.
  • Dynamic molecular library engineering.
  • Enhanced virtual compound library.
02

Adaptive Al Screening Cascade

  • Smart filtering architecture.
  • Transformer models with dynamics.
  • SHAP-guided structure optimization.
03

Wet-Dry Cycle Validation

  • Al-driven experimental module.
  • Smart experiment scheduling.
  • lterative optimization milestones.

Technology Ecosystem and Collaboration Network

Creative Biogene's AI services form a complete cycle of algorithm development-wet lab validation-industrial implementation:

Algorithm Layer

Proprietary framework supporting TensorFlow/PyTorch hybrid architecture, compatible with open-source tools like AlphaFold2.

Data Layer

Houses 200,000+ antibody sequences, 50,000+ enzyme mutant databases, and 100,000+ fermentation process parameters.

Hardware Layer

Equipped with NVIDIA DGX A100 clusters and automated high-throughput screening.

Contact us today to obtain customized AI solutions and accelerate your biopharmaceutical R&D process! All services are ISO 9001 and GLP certified, with data security compliant with international standards.

Quick Inquiry
Products

Transfected Stable Cell Lines

Premade Virus Particles

Laboratory Equipment

RNA Interference Products

Cell Lysate

Clones

Enzymes

Kits

Aptamers

Services

Stable Cell Line Generation

Target-based Drug Discovery Service

Custom Libraries Construction Service

Microbe Genome Editing Service

Biosafety Testing Service

Nucleotides Service

MicroRNA Service

RNAi Service

Custom Viral Service

Platforms

CRISPR/Cas9 PlatformCB

QvirusTM Platform

IntegrateRNA Platform

Microbiology Platform

Zebrafish Platform

Get in Touch

Tel

Fax

Email

USA

Germany

Copyright © 2026 Creative Biogene. All rights reserved.

Privacy Policy | Cookie Policy